hydrocortisone administration
Recently Published Documents


TOTAL DOCUMENTS

109
(FIVE YEARS 1)

H-INDEX

21
(FIVE YEARS 0)

2021 ◽  
Vol 126 ◽  
pp. 105168
Author(s):  
Oswald D. Kothgassner ◽  
Marie Pellegrini ◽  
Andreas Goreis ◽  
Vito Giordano ◽  
Joy Edobor ◽  
...  

2020 ◽  
Vol 6 (3) ◽  
pp. 338-343
Author(s):  
AO Adekoya ◽  
TE Adekanye ◽  
OO Abolurin ◽  
OO Adebawojo ◽  
FG Ajayi ◽  
...  

The management of neonatal hyperinsulinaemic hypoglycaemia remains a major challenge in hospitalized newborns globally. Diazoxide is one of the recommended therapeutic options. We report a late preterm, male infant of a diabetic mother who suffered severe perinatal asphyxia and had persistent hypoglycaemia requiring progressively increasing intravenous glucose concentrations to as high as 12.5 mg/kg/minute along with intravenous hydrocortisone administration. A critical sample revealed inappropriately high serum insulin, inappropriately low serum cortisol and growth hormone responses. Urinalysis was negative for ketones. With the persistence of hypoglycaemia, oral diazoxide at 5 mg/kg/day with oral hydrochlorothiazide was administered. The infant was diazoxide-responsive with complete resolution of hypoglycaemia. Diazoxide therapy was discontinued after 14 days and he was discharged after one month of admission. This report emphasizes the importance of diazoxide in the management of neonatal transient hyperinsulinaemic hypoglycaemia. The availability and cost of diazoxide, as well as the endocrine and metabolic tests, are major concerns in resource-poor settings.


2020 ◽  
Vol 2020 ◽  
pp. 1-7
Author(s):  
Hussein H. Alhawari ◽  
Sameeha Alshelleh ◽  
Hussam H. Alhawari ◽  
Izzat Ahmad Alawwa ◽  
Saif Aldeen AlRyalat ◽  
...  

Introduction. Approximately 15 to 33% of all dialysis treatments are complicated by intradialytic hypotension (IDH). In this study, we tested the hypothesis that the intravenous administration of hydrocortisone prior to HD treatment could prevent IDH or at least decrease the drop in the blood pressure resulting from IDH. Methods. This study was approved by our local ethics committee/IRB (2017/87) and by the Jordan Food and Drug Administration (7/clinical/18). Additionally, it is registered on ClinicalTrials.gov (NCT03465007). In this preliminary investigational study, we screened all chronic hemodialysis patients at our clinic who were 18 years of age or older (n=82) for IDH. There were 14 patients included in the interventional part of this study; patients were given IV hydrocortisone for 3 consecutive HD sessions, followed or preceded by 3 intervention-free sessions where they were given 5 ml of saline as a placebo. Results. The initial total sample size was 82 patients. The frequency of IDH at our clinic was 24.4%. Fourteen out of the 20 patients who were diagnosed with IDH agreed to enroll in the interventional part of our study. The mean age of the patients in the interventional part of our study was 53.5 years (±10.3). These patients included 5 (35.7%) men and 9 (64.3%) women. Upon comparing the number of hypotensive attacks with and without the hydrocortisone administration, we found a significant difference (p=0.003) between the hydrocortisone and placebo treatments in which 12 (85.7%) patients had fewer IDH episodes with the hydrocortisone treatment than with placebo. Conclusion. This preliminary investigational study found that the administration of a stress dose of hydrocortisone prior to hemodialysis could be an effective measure for preventing or minimizing the risk of IDH episodes. Additional prospective studies on this subject are needed. Ruling out adrenal insufficiency in patients diagnosed with IDH is also crucial.


2019 ◽  
Vol 80 (8) ◽  
pp. 771-778 ◽  
Author(s):  
Hye-Ryung Choo ◽  
Hakhyun Kim ◽  
Ji-Houn Kang ◽  
Chan-Joo Sung ◽  
Changhwan Ahn ◽  
...  

2018 ◽  
Vol 596 (20) ◽  
pp. 4847-4861 ◽  
Author(s):  
Ahmed M. Adlan ◽  
Jet J. C. S. Veldhuijzen van Zanten ◽  
Gregory Y. H. Lip ◽  
Julian F. R. Paton ◽  
George D. Kitas ◽  
...  

Author(s):  
M Salman ◽  
J AlKhoury ◽  
R AlSherooqi ◽  
W Assar

It’s evident in the literature that Addisonian crisis is tightly linked with cardiovascular manifestations, with very few cases reporting an associated between adrenal insufficiency and reversible cardiomyopathy. We report a case of a 57 years old lady who presented with an acute onset of adrenal insufficiency then developed severe heart failure that resolved post hydrocortisone administration. The clinical presentation, course of management and outcome will be discussed.


Sign in / Sign up

Export Citation Format

Share Document